BIOMAT Database Logo BIOMAT Database Logo

Active-passive immunization of human subjects against tetanus using homologous gamma globulin. 1974

K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva

UI MeSH Term Description Entries
D007110 Immunity, Active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
COMBINED ACTIVE-PASSIVE IMMUNIZATION AGAINST TETANUS WITH HUMAN IMMUNE GLOBULIN.
July 1965, The Medical journal of Australia,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Passive immunization against tetanus with human immune globulin.
July 1962, British medical journal,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Active immunization against tetanus in man. II. Combined active and passive prophylaxis with human tetanus immune globulin.
April 1976, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
[ACTIVE AND PASSIVE IMMUNIZATION AGAINST TETANUS].
September 1964, Orvosi hetilap,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
[Active or passive immunization against tetanus].
January 1952, Zentralblatt fur Chirurgie,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Experimental studies on passive immunization against poliomyelitis. I. Protection with human gamma globulin against intramuscular inoculation, and combined passive and active immunization.
July 1951, American journal of hygiene,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Active-Passive tetanus immunization.
April 1966, Connecticut medicine,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Combined active-passive immunization against tetanus in man.
May 1967, Canadian Medical Association journal,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
[Immune response in active-passive immunization against tetanus].
January 1986, Medicinski pregled,
K I Matveev, and S V Skurkovich, and B D Bychenko, and E M Kasparova, and N D Konstantinova, and H L Minaeva
Passive immunization with gamma globulin.
October 1966, Bulletin of the New York Academy of Medicine,
Copied contents to your clipboard!